Testicular effects induced by dermal application or dust inhalation of para-tertiary butyl benzoic acid (ptBBA) in Fischer 344 rats were investigated. Similar effects were observed from both dermal and dust inhalation studies. Reduction in testis weights, testicular sperm head counts, and LDH-X enzyme levels were observed in a dose-related fashion. A reduction or absence of spermatogenic cell types, specifically spermatids and spermatocytes in the seminiferous tubules, was observed histologically. In affected testes, some seminiferous tubules contained only Sertoli cells and few spermatogonia, whereas other tubules contained all stages of spermatogenic cells, except differentiating spermatids. Cell types sensitive to cytotoxic effects induced by ptBBA appeared to be the early spermatids and the late spermatocytes. Other cell types, late spermatids, earlier stages of spermatocytes, and differentiating spermatogonia, were also affected in higher dosage groups. These affected cells were undergoing degeneration and may not survive through the course of spermatogenesis. However, most testes demonstrated partial damage with the presence of Sertoli cells and spermatogonia as compared to the control testes, and recovery following cessation of exposure would be anticipated.
INTRODUCTION
ARA-TERTIARY BUTYL BENZOIC ACID (ptBBA) and its derivatives have had many commercial ap-P plications (e.g., paint formulations). Inhalation and dermal exposures are the most likely routes for human exposure. The testicular effect of ptBBA by oral (feeding) intake in rats has been reported,"' whereas no data are available for either of the more likely routes of exposure. Therefore, testicular toxicity of ptBBA was evaluated in both dermal and inhalation studies.
MATERIALS AND METHODS
Male Fischer 344 rats obtained from Charles River Breeding Laboratories, Inc., Kingston, New York, were maintained under controlled temperature (21-24"C), humidity (35-70%), and light cycle Shell Oil Company, H.S. & E-Toxicology Department, Houston, Texas.
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(12-hour on and 12-hour off): They were held for a minimum of 2 weeks before use as a preconditioning period to insure that they were in good health. These rats weighed 167-280 g and were greater than 9 weeks old at the time of treatment.
The test material for the 90-day dermal study was simulated cutting fluid comprised of ptBBA and diethanolamine (DEA), prepared in deionized water. The ratio of ptBBA:DEA was maintained at approximately 1.7:l .O. The sample of ptBBA was obtained from production stock at Shell Chemical Company (Houston, Texas), and DEA was obtained from Aldrich Chemical Company (Milwaukee, Wisconsin). One milliliter of simulated cutting fluid, containing 0 (water), 17.5, 35, 70, or 140 mg of ptBBA per kg body weight, was applied to the skin on the back of each rat (20 rats per group), once a day, 5 days/week, for a maximum of 13 weeks. The hair on the back of each rat was clipped before application of the test material.
The test material for both inhalation studies was a white crystalline powder (99.4% pure) of ptBBA, obtained from Shell's Martinez Chemical Plant. Rats (6 per group) were exposed to a concentration of 0 (air), 495, 668, 958, or 1802 mg of ptBBA dust in air/m3 for only 4 hours, or rats (8 per group) were exposed to a concentration of 0 (air), 12.5, 106.1, or 525.2 mg of ptBBA dust in air/m3, 6 hours/day, for 4 consecutive days, followed by 3 days rest and 3 more days exposure. Detailed procedures for dust generation and exposure condition are reported in a separate publica-
For the 90-day dermal study, testis weight, sperm count, LDH-X enzyme assay, and testicular histology were performed following 7-week (7 rats per group) and 13-week (13 rats per group) exposures. Rats were killed by C 0 2 asphyxiation. The right testis of each rat was preserved in Bouin's fixative and processed for histologic analysis. After removal of the tunica, each left testis was weighed, homogenized (Brinkman Homogenizer, Model 125 E), and sonicated (Heat System Sonicator Cell Disrupter Model 225R) in 5 ml of distilled water. Aliquots were removed, and the sperm heads were counted using a hemacytometer on a phase-contrast microscope. Two aliquots were counted from each individual sample, and a minimum of 200 sperm per chamber were counted.
The remaining sonicate was then heated to 55°C for 5 minutes in a water bath to destroy the activity of other enzymes without affecting LDH-X a~t i v i t y . '~) The sonicate was then chilled and centrifuged (Sorvall Rcfrigerated Centrifuge Model RC-5B) at 13,000 rpm for 15 minutes, and the supernatant was retained for immediate enzyme assay. The LDH-X activity was quantified spectrophotometrically by measuring the oxidation of NADH in the presence of sodium pyruvate a t 340 nm on the IL MCA Multistat I11 automated clinical analyzer from a modified method of Lu and Meistrich.(',') The assay was performed in 0.1 M sodium phosphate buffer, pH 7.5, containing as substrate 0.02 M sodium pyruvate and 1.13 x lo-. M NADH. The amount of LDH-X activity was calculated in units. One unit of enzyme corresponded to the oxidation of l pmol NADH per minute at 30°C under the specified condition. For inhalation studies, testis weight, sperm count, and testicular histology were performed for each scheduled kill rat. Rats from the 4-hour acute dust inhalation study were killed 14 days after exposure, and rats from the 7-day dust inhalation study were killed on the day after the last exposure. All rats found dead or moribund were autopsied immediately, and testicular histology was performed.
Data for testis weight, sperm count, and LDH-X activity were analyzed by one-way analysis of variance. Comparison between treatment and control means was performed by one-tailed Wilcoxon 2-sample rank sum test or Dunnett's t-test at P = 0.05.
RESULTS

Ninety-day dermal study
Testicular effects induced by ptBBA were noted only in rats of the 70 and 140 mg/kg groups. Significantly (P < 0.01) lower testis weight, sperm head count, and LDH-X enzyme activity were obtained for rats in these two groups as compared to those of the controls following 7-week ( Histologically, the effect on spermatogenesis induced by ptBBA after 7 or 13 weeks exposure was only seen in the rats from the two highest dosage groups. Most seminiferous tubules contained spermatogonia, spermatocytes, early (round) spermatids, and Sertoli cells (supporting cells) but were devoid of late spermatids (Fig. 3) . Occasionally, few seminiferous tubules in the same testis contained only Sertoli cells and a few spermatogonia (Fig. 4) . Multinucleated giant cells containing several degenerated cells were often present in the lumina of the seminiferous tubules (Fig. 5 ) . A reduction in number of spermatogenic cell types and the absence of late spermatids were the most striking findings in the testes of rats after 7 or 13 weeks exposure to ptBBA. The degree of damage to individual seminiferous tubules and to individual rats varied among the top two dosage groups when compared with the controls. LU ET AL. 
TESTICULAR EFFECTS INDUCED BY ptBBA IN RATS
Four-hour acute dust inhalation study
A dose-related testicular effect induced by ptBBA exposure was noted for rats in all dose groups.
Significantly ( P < 0.05) lower testis weights and testicular sperm counts were obtained 14 days after exposure in all ptBBA-treated rats as compared to controls (Fig. 6) . The effect on spermatogenesis induced by ptBBA was evaluated by histologic analyses. Late spermatids were absent in the seminiferous tubules of the testes of rats in the lower dose groups (Fig. 7) . However, all stages of differentiating spermatids were absent in the highest dose group, 1802 mg/m' (Fig. 8) . Tubules containing only Sertoli cells and tubules with multinucleated giant cells were prevalent, as noted in the dermal study.
Seven-day dust inhalation study
Repeated exposure of rats to ptBBA dust resulted in deaths at concentrations of 106 and 525 mg of ptBBA/m3. There were 2 of 8 males in the 106 mg/m3 group and 7 of 8 males in the 525 mg/m3 group that died during the exposure period. No death resulted following seven repeated exposures to 12.5 mg of ptBBA/m' or in the control group. Significantly ( P < 0.01) lower testis weights were observed for rats in the top two dosage groups, 106 and 525 mg of ptBBA/m3. However, lower testicu- lar sperm counts were obtained in all dosage groups, the 12.5, 106, and 525 mg of ptBBA/m3 after 7 days exposure when compared to the controls (Fig. 9) . The values of mean testis weight were 1.24, 1.27, 0.87, and 0.31 g/testis, and the values of sperm count/testis were 236.5, 188.0, 93.0, and 9.7 million for the 0 (control)., 12.5, 106, and 525 mg of ptBBA/m' dosage groups, respectively.
From histologic evaluations 10 days after the first exposure, there was no apparent effect on spermatogenesis from ptBBA treatment in the low dose (12.5 mg/m3) group. Absence of late spermatids, presence of multinucleated giant cells, and reduction in spermatogenic cell types were observed in the testes from the middose (106 mg/m3) group rats (Fig. 10) . The testis of a single surviving rat from the high dose (525 mg/m3) group contained only Sertoli cells and a few spermatogonia in its tubules (Fig. 11) . The chronology of the degenerative process of cells in the seminiferous tubules was observed from the high dose group (525 mg/m') rats that died or were killed at various time intervals after exposure. On days 1-3, six rats were found dead, and there were degenerating spermatocytes and early spermatids, as evidenced by the vacuolated and pyknotic nuclei in the testes of these rats. The SertoIi cell cytoplasm contained several vacuoles, and severat multinucleated giant cells (Fig. 12) . On day 7, one rat was found dead, and there were degenerating spermatocytes but no early or mid spermatids in the testis. On day 10, the seminiferous tubules contained only Sertoli cells and a few spermatogonia but were devoid of other differentiatinggerm cells in the testis of the only surviving rat.
DISCUSSION
To cause a 50% reduction in rat testis weight, the required doses of ptBBA are estimated to be 800 mg/m3, 220 mg/m3, and 80 mg/kg/day by 4-hour inhalation, 7-day inhalation, and 7-or 13-week dermal exposure, respectively. Hunter et aI.(l) reported that a single oral dose of 500 mg/kg or greater caused testicular atrophy and reduced testis weight to 50-60% of the normal value. These findings suggest that a single high dose exposure of 500 mg/kg[I) or repeated low dose exposures of 80 mg/kg (present study) to ptBBA can equally induce the same effect on testis weight. Hunter et al. also reported that 750 ppm of ptBBA fed to rats for 90 days caused a 50% reduction in testis weight. This suggests that the oral route of exposure is comparable or slightly more potent than the dermal route for induction of testicular effect. In the dermal study, a dose of 35 mg/kg or less did not affect the testis weight. This suggests that the amount of ptBBA absorbed through skin and reaching the testis may be less than the toxicity threshold level. LU ET AL. 
TESTICULAR EFFECTS INDUCED BY ptBBA IN RATS
To reduce the sperm count t o 50% of the control value, the required doses of ptBBA were approximately 250 mg/m', 75 mg/m', and 40 mg/kg/day by 4-hour inhalation, 7-day inhalation, and 7-or 13-week dermal exposure, respectively. However, no effect on sperm count was observed at low dose levels, 35 mg/kg/day or less, during the 13-week dermal exposure to ptBBA. This result further suggests that the amount of ptBBA absorbed through the skin and reaching the testis may be less than a threshold level. However, the effect on sperm count induced by ptBBA inhalation was linear; at the lowest dose, 12.5 mg/m3, the testis weight was not even affected. Thus, assay of sperm counts was a more sensitive measurement than the testicular weight in dtecting ptBBA-induced toxicity in this organ.
Assays of sperm count and LDH-X activity were to measure the effect of ptBBA on spermatogenic cells, specifically, spermatocytes and spermatids. The sperm count assay measured elongated spermatids, whereas, LDH-X activity measured surviving spermatocytes and spermatids. ( s , b ) The results from these assays correlated well with the histologic findings.
LDH-X activity was only evaluated in rats receiving repeated dermal exposures. The values of mean LDH-X level after 7 weeks of exposure to 70 or 140 mg/kg/day were 56% and 35% of the control value, respectively; after 13 weeks of exposure, they were 48% and 33% of the control value, respectively. The LDH-X activity after 13 weeks of exposure was lower than after 7 weeks of exposure, which suggests that there was partial damage to the germinal epithelia and only specific cell types were affected. This interpretation was consistent with the histologic findings of multifocal tubular atrophy but interspersed tubules of spermatogonia and spermatocytes and few or no late spermatids. Degeneration of early spermatids was the first lesion seen in a rat found dead 1 day after exposure to 525 mg/m' of ptBBA dust. Degenerating spermatocytes and spermatids were noted in rats killed at subsequent necropsies. After the repeated dermal exposure to ptBBA, most spermatids, if not all, were absent. One of the high dosage rats was moribund and killed 2 weeks after repeated dermal exposure to ptBBA, and there were no spermatids in the testes or mature sperm in the corresponding epididymides.(') This indicates the cytotoxicity of ptBBA on spermatids, regardless of the route of exposure to ptBBA. After exposure to high doses of ptBBA, spermatogonia and the subsequent differentiating germ cells were also affected; therefore, some seminiferous tubules contained only Sertoli cells, and possibly a few spermatogonia, but were devoid of other germ cells. Varying degrees of tubular degeneration arising from multifocal to diffuse necrosis of spermatocytes and spermatids and the formation of intraluminal multinucleated giant cells arising from sloughed and degenerated cells were noted among the treated groups. The hypothesis of spermatid toxicity was further supported by the absence of sperm in the epididymides of rats repeatedly exposed dermally to ptBBA for 7 weeks (Fig. 13) and 13 weeks (Fig. 14) . These results demonstrated that the early spermatids were the most sensitive cell type to ptBBA-induced cytotoxic effects. The lowest doses of ptBBA reported to cause testicular lesions were 100 ppm in a 90-day feeding study by Hunter et al.,(') 12.5 mg/m3 in our 7-day inhalation study, and 70 mg/kg/day in our 90-day dermal study. These results support the earlier hypothesis that the dermal route of exposure is less potent in the induction of testicular toxicity than are other routes.
CONCLUSIONS
Testicular effects in rats can be induced by ptBBA either by dermal application or inhalation, although dermal application at a dose of 35 mg/kg or less will not cause any testicular effect. There appeared to be a threshold for this effect, presumably due to retarded absorption through skin barrier. Exposure by inhalation resulted in a linear dose-response curve similar to that reported by Hunter et al.(') in their 90-day feeding study.
Testicular effects can be localized to specific cell stages of spermatogenesis by these parameters: testis weight, testicular sperm counts, LDH-X activity and testicular histology. Data presented herein demonstrate the greatest sensitivity of ptBBA is in the spermatid stage. At higher doses, all LU ET AL. 
FIG.
14. The epididymis from a rat treated with 140 mg/kg/day of ptBBA by dermal application for 13 weeks. Note the tubules contain multinucleated giant cells (arrows), and absence of sperm. x 400.
stages of spermatogenesis may exhibit cytotoxicity, beginning with the spermatocytes. However, most testes demonstrzted partial damage with the presence of some stem cells or spermatogonia for regeneration. Thus, recovery following cessation of exposure would be anticipated. 
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